Publications by authors named "M F Thorpe"

Claim this Profile
R
Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysis.
Saurabh Zanwar, Gokce Belge Bilgin, Stephen M Broski, Matthew Thorpe, Cem Bilgin

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Peptide Receptor Radionuclide Therapy with Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma.
Gokce Belge Bilgin, Brian J Burkett, Cem Bilgin, Jolanta M Durski, Ann T Packard, Matthew P Thorpe

J Nucl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction of a single carboxylic acid converts the cyclic oligomeric depsipeptide ent-verticilide from a ryanodine receptor 2 (RyR2) inhibitor to RyR2 activator.
Tri Q Do, Daniel J Blackwell, Abigail N Smith, Madelaine P Thorpe, Robyn T Rebbeck

Mol Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for [Lu]Lu-PSMA-617 with and Without Concurrent Use of Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration-resistant Prostate Cancer.
Miguel Muniz, Oliver Sartor, Jacob J Orme, Regina M Koch, Zachary Scharf, Matthew P Thorpe

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of PET-CT to Assess the Extent of Nodal Disease in Patients with Clinical Stage III Melanoma Following Neoadjuvant Treatment.
Ronen Stoff, Mariana Yalon, Matthew P Thorpe, Thomas J Flotte, Matthew S Block

Ann Surg Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis